Previous close | 19.89 |
Open | 19.89 |
Bid | 27.80 |
Ask | 37.00 |
Strike | 210.00 |
Expiry date | 2022-09-16 |
Day's range | 22.89 - 22.89 |
Contract range | N/A |
Volume | |
Open interest | 8 |
ACTON, Mass., June 30, 2022--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the second quarter of 2022 on August 4, 2022 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).
While Insulet Corporation ( NASDAQ:PODD ) shareholders are probably generally happy, the stock hasn't had particularly...
Insulet's (PODD) Omnipod 5 showed improved time in range and lower HbA1c for pre-school children during an extended phase of the previous pivotal trial.